淋巴瘤
骨髓
医学
入射(几何)
病理
病态的
活检
套细胞淋巴瘤
内科学
光学
物理
作者
Qing Chen,Lu-Ting Zhu,Xiaowei Cen,Zeyin Liang,Ou Jiang,Lihong Wang,Wensheng Wang,Wei Liu,Zhi-Xiang Qiu,Yujun Dong,Mangju Wang,Yu-Hua Sun,Yue Yin,Qian Wang,Hanyun Ren
出处
期刊:PubMed
日期:2018-06-01
卷期号:26 (3): 765-771
标识
DOI:10.7534/j.issn.1009-2137.2018.03.022
摘要
To analyze the incidence of bone marrow involvement in patients with different pathological types of lymphoma.The results of bone marrow tests including bone marrow aspiration(BMA), flow cytometry detection, bone marrow biopsy(BMB) and 18F-FDG PET/CT, were analyzed retrospectively in 702 cases of newly diagnosed lymphoma with bone marrow assessment in our hospital from October 2000 to September 2016. If one of the above-mentioned 4 tests showed positive, the lymphoma patient was judged as bone marrow involved.The incidence of bone marrow involvement (BMI ) in the patients with NHL was much higher than that in patients with HL [32.6 %(201/616) vs 15%(13/86)](P<0.05). For patients with NHL, the incidence of bone marrow involvement in B-cell lymphoma was higher than that in T-cell lymphoma (37.0% vs 22.6%)(P<0.05). According to different pathological types, the incidences of BMI in the patient with mantle cell lymphoma, hepatosplenic T-cell lymphoma, diffuse large B-cell lymphoma (DLBCL) and follical lymphoma (FL) were 88% (25/22), 100% (5/5), 21.8% (56/257), and 38.5% (15/39) , respectively.The incidence of bone marrow involvement varies in different pathological types of lymphoma.Bone marrow assessment has significant importance for stading of newly diagnosed lymphoma patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI